Allocation of R&D investments in pharmaceutical industry by function 2018

This statistic displays the pharmaceutical industry's research and development investment allocation by select functions in 2018. The pharmaceutical industry spent 16.4 percent of research and development investments during pre-human or pre-clinical stages.

Allocation of research and development investments in pharmaceutical industry in 2018, by function

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

2020

Region

Worldwide

Survey time period

2018

Supplementary notes

EFPIA: European Federation of Pharmaceutical Industries and Associations
* Phase I to III are part of clinical trials.
Note: PhRMA, Annual Membership Survey 2019 (percentages calculated from 2018 data; total values may be affected by rounding)

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Research and development (R&D) worldwide"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.